Ascendis Pharma A/S Data From Phase 2 PaTH Forward Study Of TransCon PTH Demonstrates Sustained Efficacy, Safety In Participants With Hypoparathyroidism

뉴스 본문을 불러오고 있어요.

Ascendis Pharma A/S Data From Phase 2 PaTH Forward Study Of TransCon PTH Demonstrates Sustained Efficacy, Safety In Participants With Hypoparathyroidism | 웨이프 WAPE

Ascendis Pharma A/S Data From Phase 2 PaTH Forward Study Of TransCon PTH Demonstrates Sustained Efficacy, Safety In Participants With Hypoparathyroidism

기사 요약

관련 종목

댓글 —